Transaction · 0001193125-26-380023

Lee Willis C

LEE WILLIS C, CEO, reported an open-market or private purchase at Emmaus Life Sciences, Inc. involving 50000.000000 shares for an estimated $2500.00. Reported holdings after the transaction were 495400.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PCEO
EMMAEmmaus Life Sciences, Inc.
Trade date
Aug 27, 2026
Filing date
Sep 02, 2026
View on SEC Insider profile
Estimated value$2.50kShares × reported price
Shares traded50.0k$0.05 per share
Holdings after495kIndirect · Fidelity Roth IRA FBO Willis C. Lee
% of reported position traded11.23%This security and ownership context
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 445,400 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 6 calendar days after the transaction date.

EMMA price since this filing

Daily closing prices, with the filing date and available return windows
EMMA · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001193125-26-380023
Common stock, $0.001 par value
Transaction date
Aug 27, 2026
Filed Sep 02, 2026, 07:05 PM · 6d delay
Shares
50,000 sh
$0.05 per share
Estimated value
$2.50k
Computed from shares × price
Holdings after
495,400 sh
Indirect · Fidelity Roth IRA FBO Willis C. Lee

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
CEO Buy Delayed Filing Director Buy
Filing-only score

+18 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • open_market_purchase+12 points

    transaction_code = P

    Code P is a discretionary open-market purchase.
  • ceo_buy+12 points

    is_officer + officer_title/role mentions CEO

    CEO open-market purchase.
  • delayed_filing-6 points

    reporting_delay_days = 6

    Filing delay exceeds the configured threshold.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.01 to $0.02, inclusive. The reporting person undertakes to provide to Emm…

  2. F2

    The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.0109 to $0.011, inclusive.

  3. F3

    The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.034 to $0.039, inclusive.

  4. F4

    The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.044 to $0.051, inclusive.

  5. F5

    The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.050 to $0.075, inclusive.

  6. F6

    The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.046 to $0.05, inclusive.

Original filing · 0001193125-26-380023
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

EMMA